Last reviewed · How we verify
Platelet-Rich Plasma and Fibrin Glue — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Platelet-Rich Plasma and Fibrin Glue (Platelet-Rich Plasma and Fibrin Glue) — Daryoush Hamidi Alamdari, PhD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Platelet-Rich Plasma and Fibrin Glue TARGET | Platelet-Rich Plasma and Fibrin Glue | Daryoush Hamidi Alamdari, PhD | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Platelet-Rich Plasma and Fibrin Glue CI watch — RSS
- Platelet-Rich Plasma and Fibrin Glue CI watch — Atom
- Platelet-Rich Plasma and Fibrin Glue CI watch — JSON
- Platelet-Rich Plasma and Fibrin Glue alone — RSS
Cite this brief
Drug Landscape (2026). Platelet-Rich Plasma and Fibrin Glue — Competitive Intelligence Brief. https://druglandscape.com/ci/platelet-rich-plasma-and-fibrin-glue. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab